Clinical
RSSArticles
-
Clinical Briefs
A closer look at non-alcoholic fatty liver disease, lifting the ban on total dietary fat, and the risks of digoxin use in AF patients.
-
Cholic Acid Capsules (Cholbam ®)
The cholic acid capsule is the first FDA-approved treatment for rare bile acid synthesis disorders.
-
Inferior Vena Cava Filters and Recurrent Pulmonary Embolism
Placement of retrievable inferior vena cava filters in individuals with concurrent deep vein thrombosis does not reduce the risk of recurrent pulmonary embolism.
-
Long-term Weight Loss Rivals Medications and Ablation for AF Rhythm Control
The authors conclude long-term sustained weight loss was possible and was associated with a significant reduction in atrial fibrillation burden.
-
Provocative Cardiovascular Testing for Everyone with Chest Pain?
ABSTRACT & COMMENTARY: Pain or not, it's hard to take money out of the medical equation.
-
Tramadol for Premature Ejaculation
On-demand doses of 25-50 mg tramadol administered 2-4 hours prior to intercourse is effective in prolonging vaginal ejaculatory latency time.
-
Predicting Which Patients with Non-alcoholic Fatty Liver Disease Will Progress
Certain non-alcoholic fatty liver disease patients have a progressive type called non-alcoholic steatohepatitis, which itself may progress to cirrhosis and hepatocellular carcinoma.
-
Preventing Recurrence of Depression: Cognitive Therapy or Medication?
Over a 24-month interval, slightly fewer than half of the subjects experienced relapse, with no significant difference demonstrable between mindfulness-based cognitive therapy and pharmacotherapy.
-
How Long Should We Treat with Warfarin for Symptomatic Venous Thromboembolism?
Long-term anticoagulation was associated with about an 80% reduction in recurrent venous thromboembolic events compared to short-term anticoagulation.
-
Stroke Accelerates Long-term Process of Cognitive Decline
Following an acute stroke, executive function declined significantly — more steeply than in controls; encouragingly, the capacity for new learning post-stroke did not decline.